0001127602-18-024251.txt : 20180801 0001127602-18-024251.hdr.sgml : 20180801 20180801160637 ACCESSION NUMBER: 0001127602-18-024251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180801 DATE AS OF CHANGE: 20180801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TEN HOEDT ROB CENTRAL INDEX KEY: 0001610036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 18984791 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MSLC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0424 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-07-30 0001613103 Medtronic plc MDT 0001610036 TEN HOEDT ROB 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 1 EVP & President EMEA Ordinary Shares 2018-07-30 4 A 0 9730 0 A 71062 D Stock Option (Right to Buy) 89.08 2018-07-30 4 A 0 58745 0 A 2019-07-30 2028-07-30 Ordinary Shares 58745 58745 D Stock Option (Right to Buy) 89.08 2018-07-30 4 A 0 1695 0 A 2019-07-30 2028-07-30 Ordinary Shares 1695 1695 D The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. This balance increased by 906 shares due to exempt transactions such as dividend reinvestment. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. /s/ Rhonda L. Ingalsbe, Attorney-in-fact 2018-08-01